Janux Therapeutics, Inc. (JANX) vs Nuvalent, Inc. (NUVL)
Detailed comparison between Janux Therapeutics, Inc., Nuvalent, Inc..Total Return (%)
Janux Therapeutics, Inc. (JANX)Nuvalent, Inc. (NUVL)
Which stock do you think will perform better?
Janux Therapeutics, Inc.
JANX
Nuvalent, Inc.
NUVL
| Metric | Janux Therapeutics, Inc. (JANX) | Nuvalent, Inc. (NUVL) |
|---|---|---|
| Current Price | $22.62 | $71.02 |
| Change | -2.71 (-10.70%) | -0.40 (-0.56%) |
| Market Cap | $1.34B | $5.10B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -14.14 | -16.75 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $71.71 | $113.51 |
| 52-Week Low | $22.48 | $55.53 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-1.36 | $-4.42 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| JANX | -21.16% | -44.30% | -52.39% | -10.06% | -10.06% | -10.06% |
| NUVL | 1.50% | -6.54% | -2.23% | 278.77% | 278.77% | 278.77% |